![Nicholas Virca](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Virca
Algemeen Directeur bij
Hedgepath LLC
Vermogen: 776 749 $ op 31-08-2026
Profiel
Nicholas Jon Virca is currently the President, Chief Executive Officer & Director at Hedgepath LLC since 2012.
Previously, he held the position of President & Chief Executive Officer at Mast Therapeutics, Inc. from 1997 to 2004.
He also served as the President & Chief Executive Officer at Inhibitor Therapeutics, Inc. from 2014 to 2022.
Additionally, he worked as a Director at Panoptix Events from 2007 to 2017 and as a Director at Diametrix Detectors, Inc. from 1991 to 1997.
Furthermore, he held the role of Vice President-Global Biotechnology at Pall Corp.
and Cytiva US LLC from 2005 to 2008.
Lastly, he served as the Chief Operating Officer at LamdaGen Corp.
from 2008 to 2012.
Mr. Virca obtained his undergraduate degree from Youngstown State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-08-2026 | 8.727.519 ( 5,02% ) | 776 749 $ | 31-08-2026 |
Actieve functies van Nicholas Virca
| Bedrijven | Functie | Begin |
|---|---|---|
Hedgepath LLC | Algemeen Directeur | 01-04-2012 |
Eerdere bekende functies van Nicholas Virca
| Bedrijven | Functie | Einde |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Algemeen Directeur | 13-12-2022 |
Panoptix Events
 Panoptix Events Miscellaneous Commercial ServicesCommercial Services Operates as a event planning agency | Directeur/Bestuurslid | 01-01-2017 |
LamdaGen Corp.
 LamdaGen Corp. Miscellaneous Commercial ServicesCommercial Services Develops proprietary biosensors and instruments | Operationeel Directeur | 01-04-2012 |
| PALL CORPORATION | Corporate Officer/Principal | 01-01-2008 |
Cytiva US LLC
 Cytiva US LLC BiotechnologyHealth Technology Develops and manufactures of biotherapeutics, cell and gene therapies | Corporate Officer/Principal | 01-01-2008 |
Opleiding van Nicholas Virca
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
37
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Pall Corp.
 Pall Corp. Industrial MachineryProducer Manufacturing Designs, manufactures and markets filtration & separation equipment | Producer Manufacturing |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Hedgepath LLC | |
Youngstown State University
 Youngstown State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Develops and manufactures of biotherapeutics, cell and gene therapies | Health Technology |
LamdaGen Corp.
LamdaGen Corp. Miscellaneous Commercial ServicesCommercial Services Develops proprietary biosensors and instruments | Commercial Services |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Panoptix Events
Panoptix Events Miscellaneous Commercial ServicesCommercial Services Operates as a event planning agency | Commercial Services |
Diametrix Detectors, Inc. |
